Related Experiment Video
Updated: May 8, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningitis due to Neisseria meningitidis serogroup B in India
Meenakshi Aggarwal1, Vikas Manchanda, B Talukdar
1Departments of Clinical Microbiology and Infectious Diseases Division, Chacha Nehru Bal Chikitsalaya, Raja Ram Kohli Marg, Geeta Colony, Delhi, India.
Abstract:
Invasive meningococcal disease has a fulminant course and high mortality. Neisseria meningitidis serogroup A is predominantly responsible for meningococcal disease in India and the developing countries. Group B meningococcus, which is prevalent in the developing world is uncommon in India. We herein report the second case of group B meningococcal infection from the country, two decades after the reporting of the first case. Ineffective vaccines against serogroup B warrant the need for close surveillance of this disease.
Insights
Invasive meningococcal disease (IMD) caused by serogroup B is rare in India. This report details the second case of group B meningococcal infection in India, highlighting the need for enhanced surveillance due to ineffective vaccines.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Invasive meningococcal disease (IMD) presents a severe clinical course with high mortality rates.
- Neisseria meningitidis serogroup A is the primary cause of IMD in India and other developing nations.
- Serogroup B meningococcus, common globally, is historically infrequent in India.
Observation:
- This paper documents the second reported case of group B meningococcal infection in India.
- The first case was reported two decades prior to this current case.
- The rarity of serogroup B meningococcal infections in India is notable.
Findings:
- The study confirms a rare occurrence of Neisseria meningitidis serogroup B in India.
- This finding contrasts with the predominant serogroup A strains typically seen in the region.
- The case underscores the potential for underdiagnosis or misdiagnosis of serogroup B strains in India.
Implications:
- The emergence of serogroup B meningococcal infections necessitates updated public health surveillance in India.
- Current vaccines are not effective against serogroup B, emphasizing the need for new vaccine development.
- Enhanced monitoring is crucial for timely detection and management of invasive meningococcal disease caused by less common serogroups.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Encephalitis l: Introduction
Brain Abscess l: Introduction
Arboviral Encephalitis

